Cryoablation appears to work best in specific subtypes of breast cancer, particularly those that are early-stage, hormone receptor-positive (ER+/PR+), and HER2-negative (HER2-), especially tumors that are small, low-grade, and unifocal. The gene discussed is NR4A1; the disease is breast carcinoma.